Hatala M A, Powers C A
Department of Pharmacology, New York Medical College, Valhalla 10595.
Biochim Biophys Acta. 1987 Dec 7;926(3):258-63. doi: 10.1016/0304-4165(87)90211-x.
Glandular kallikrein has recently been identified as an estrogen-induced protein of the rat anterior pituitary. This study examined the dynamics of the estrogen induction of anterior pituitary glandular kallikrein in the ovariectomized rat. The estrogen induction of uterine dry weight was also examined for purposes of comparison. 17 beta-Estradiol (0.1-100 micrograms/day) produced dose-dependent increases in anterior pituitary glandular kallikrein, with the highest dose producing a 60-fold increase. Time-course studies demonstrated that a lag phase of 2-3 days was required before these estrogen effects on glandular kallikrein became evident, and levels were still rising between 7 and 10 days of treatment. The dynamics of the estrogen induction of glandular kallikrein resembled the estrogen induction of uterine dry weight with regard to estrogen sensitivity and the presence of a lag phase before estrogen-induced increases. However, uterine dry weight responded more rapidly to estrogen than did anterior pituitary glandular kallikrein, and reached a plateau after 5 days of estrogen treatment.
腺激肽释放酶最近被确定为大鼠垂体前叶中一种雌激素诱导蛋白。本研究检测了去卵巢大鼠垂体前叶腺激肽释放酶雌激素诱导的动态变化。为作比较,还检测了雌激素对子宫干重的诱导作用。17β-雌二醇(0.1 - 100微克/天)使垂体前叶腺激肽释放酶呈剂量依赖性增加,最高剂量时增加了60倍。时间进程研究表明,雌激素对腺激肽释放酶产生这些作用之前需要2 - 3天的滞后阶段,且在治疗7至10天期间水平仍在上升。就雌激素敏感性以及雌激素诱导增加之前存在滞后阶段而言,腺激肽释放酶雌激素诱导的动态变化类似于子宫干重的雌激素诱导。然而,子宫干重对雌激素的反应比垂体前叶腺激肽释放酶更快,且在雌激素治疗5天后达到平台期。